Working Group on a New Grand Bargain for Antimicrobial Procurement
June 27, 2022
While there have been high-level commitments from the World Health Assembly, the United Nations General Assembly (UNGA), the G20, and the G7 to tackle AMR, there has yet to be a fundamental change in how we purchase antimicrobials, or an international approach to improving access, fostering innovati...
Working Group on New Evidence Tools for Policy Impact
June 01, 2021
CGD recently launched a working group to consider how the next generation of investments in impact evaluations—as part of the broader evidence and data ecosystem—can enhance their usefulness, responsiveness, and relevance for public policy decision-making. A renewed agenda is needed to help increase...
The ‘Learning at Scale’ Advisory Group
October 08, 2019
Learning outcomes are low and instruction is poor in many countries in the Global South. Improving learning outcomes has proven to be difficult, although the number of successful programs is growing. The effective examples have seldom been implemented at large scale, however; and the large-scale suc...
The Future of US Government Development Assistance to Fragile States
August 13, 2018
Drug Resistance Working Group (November 2007 – June 2010)
September 10, 2014
Value for Money: An Agenda for Global Health Funding Agencies
August 25, 2014
As international commitments become more ambitious and aid resources become increasingly constrained, global health funding agencies are seeking to improve the efficiency and impact of their investments. This growing “value for money” (VfM) agenda aims to reduce costs, increase imp...